Evaluation of guided bone regeneration in collagen-curcumin-aspirin membrane

Comparison of guided bone regeneration of collagen-curcumin-aspirin membrane with commercial collagen membrane in patients who needed alveolar ridge augmentation for implant placement

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200919048756N2

Enrollment

Registered

2021-01-20

Start date

2021-02-02

Completion date

Unknown

Last updated

2021-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Guided bone regeneration (GBR) to improve bone defects.

Interventions

Control group: One of the patient's implants is considered as a control in which a commercial collagen membrane (Regen, Germany) is placed in the lower tissue of the implant and then the tissue is sut

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients who need implant placement and alveolar ridge augmentation at the same time.

Exclusion criteria

Exclusion criteria: People with poor oral health Smokers Alcoholics People with diabetes People with high blood pressure or other systemic diseases

Design outcomes

Primary

Measure	Time frame
New bone formation. Timepoint: Two months after implant and membrane placement. Method of measurement: Radiographic imaging.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAmir Hossein Bani Shahabadi

Tabriz University of Medical Sciences

a_banishahabadi@yahoo.com+98 41 3335 3161

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026